Nat Simons Charles River Laboratories International, Inc. Transaction History
Meritage Group LP
- $3.66 Billion
- Q4 2024
A detailed history of Nat Simons (Meritage Group LP) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Meritage Group LP holds 1,074,120 shares of CRL stock, worth $178 Million. This represents 5.41% of its overall portfolio holdings.
Number of Shares
1,074,120
Previous 1,185,167
9.37%
Holding current value
$178 Million
Previous $233 Million
15.07%
% of portfolio
5.41%
Previous 6.2%
Shares
6 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$841 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$674 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$361 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$299 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.41B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...